Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
J Rheumatol. 2011 Apr;38(4):672-9. doi: 10.3899/jrheum.100799. Epub 2011 Jan 15.
Fatigue is a common symptom of systemic lupus erythematosus (SLE). Our objective was to validate the 13-item Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue scale in patients with SLE.
The FACIT-Fatigue, Medical Outcomes Study Short-Form-36 (SF-36) questionnaire, Brief Pain Inventory (BPI), and Patient Global Assessment Visual Analog Scale (Patient-GA) were completed at baseline and at Weeks 12, 24, and 52 by patients with moderately to severely active extrarenal SLE. The patients were participating in a rituximab clinical trial. The British Isles Lupus Assessment Group (BILAG) disease activity index and the Physician Global Assessment Visual Analog Scale (Physician-GA) were completed by physicians at the same visits.
At baseline, 254 patients completed the FACIT-Fatigue scale. Cronbach's α was > 0.95 at all visits. In cross-sectional analyses, FACIT-Fatigue scores differentiated between groups defined by BILAG General domain ratings. FACIT-Fatigue had moderate-high correlations (r = 0.5-0.8) with SF-36, BPI, and Patient-GA, but poor correlations with BILAG total score and Physician-GA (r = 0.1-0.3). At Weeks 12, 24, and 52, mean FACIT-Fatigue scale improvement was higher in patients who improved versus those who remained unchanged on the BILAG General domain. FACIT-Fatigue scale scores remained stable for patients with worsened BILAG General domain ratings compared to baseline. Distribution and anchor-based estimates suggested a minimally important difference (MID) range of 3-6 points.
The FACIT-Fatigue scale is a valid and responsive measure of fatigue in patients with SLE. MID in this SLE sample is similar to that derived previously in other populations. Since few patients experienced worsening BILAG General and Musculoskeletal domains in this study, further research is warranted to evaluate the responsiveness of FACIT-Fatigue to worsening of these domains.
疲劳是系统性红斑狼疮(SLE)的常见症状。我们的目的是验证慢性疾病治疗功能评估(FACIT)-疲劳量表在 SLE 患者中的 13 项。
基线时,中度至重度活动性肾外 SLE 患者完成 FACIT-疲劳量表、医疗结果研究短型 36 项(SF-36)问卷、简明疼痛量表(BPI)和患者总体评估视觉模拟量表(Patient-GA),并在第 12、24 和 52 周进行评估。这些患者正在参加利妥昔单抗临床试验。英国狼疮评估组(BILAG)疾病活动指数和医生总体评估视觉模拟量表(Physician-GA)由医生在同一时间进行评估。
基线时,254 名患者完成了 FACIT-疲劳量表。所有就诊时 Cronbach's α均> 0.95。在横断面分析中,FACIT-疲劳评分在 BILAG 一般领域评分定义的组之间存在差异。FACIT-疲劳与 SF-36、BPI 和 Patient-GA 具有中度至高度相关性(r = 0.5-0.8),但与 BILAG 总分和 Physician-GA 相关性较差(r = 0.1-0.3)。在第 12、24 和 52 周时,BILAG 一般领域改善的患者比保持不变的患者的 FACIT-疲劳量表改善更高。与基线相比,BILAG 一般领域评分恶化的患者的 FACIT-疲劳量表评分保持稳定。分布和基于锚定的估计表明,最小重要差异(MID)范围为 3-6 分。
FACIT-疲劳量表是一种有效的、敏感的 SLE 患者疲劳评估工具。在这个 SLE 样本中,MID 与之前在其他人群中得出的结果相似。由于在这项研究中很少有患者在 BILAG 一般和肌肉骨骼领域出现恶化,因此需要进一步研究以评估 FACIT-疲劳对这些领域恶化的反应性。